Needham & Company Reiterates a 'Buy' on Tesla Motors (TSLA); Unveils Impressive Model X, Model S on Schedule
Get Alerts TSLA Hot Sheet
Price: $345.13 --0%
Rating Summary:
29 Buy, 26 Hold, 16 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
29 Buy, 26 Hold, 16 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Needham & Company reiterates a 'Buy' on Tesla Motors (NASDAQ: TSLA) price target of $35.00.
Analyst, Michael Lew, said, "Tesla Motors unveiled the impressive looking Model X crossover electric vehicle -- an SUV with a minivan interior. The price will range from $60,000 (210 mile driving range) to $85,000 (270 miles). The company’s objective is to begin production in late-2013. Importantly, Model S production is still on target for the onset of customer deliveries at mid-year. In our view, Tesla is executing and is positioned to benefit from the secular shift towards the electrification of transportation in the long-term."
For an analyst ratings summary and ratings history on Tesla Motors click here. For more ratings news on Tesla Motors click here.
Shares of Tesla Motors closed at $32.58 yesterday.
Analyst, Michael Lew, said, "Tesla Motors unveiled the impressive looking Model X crossover electric vehicle -- an SUV with a minivan interior. The price will range from $60,000 (210 mile driving range) to $85,000 (270 miles). The company’s objective is to begin production in late-2013. Importantly, Model S production is still on target for the onset of customer deliveries at mid-year. In our view, Tesla is executing and is positioned to benefit from the secular shift towards the electrification of transportation in the long-term."
For an analyst ratings summary and ratings history on Tesla Motors click here. For more ratings news on Tesla Motors click here.
Shares of Tesla Motors closed at $32.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- The Biggest Winners Don't Compete in a Category. They Rewrite It. One Company Is Betting It Can Too.
- Tesla readies August launch of CyberCab - The Information
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Needham & Company, TeslaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share